The Federal Trade Commission's (FTC) oversight role in the pharmaceutical market is critical to the health of patients and the health care system. This study characterized the FTC's policy on the pharmaceutical market in recent decades, identifying the types of actions it has favored, barriers it has faced, and authorities that remain untested.
No takes yet. Share an insight, caveat, or question.
Daval et al. (2024) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: